Showing results (331-340 of 3,384) with videos related to
Sort By:
Pageof 339
CNS Neuroscience & Therapeutics|July 31, 2019
Risk factors for hemorrhage of brain arteriovenous malformationSonali S Shaligram, Ethan Winkler, Daniel Cooke, et al.CNS Neuroscience & Therapeutics|May 11, 2011
Naltrexone depot formulations for opioid and alcohol dependence: a systematic reviewPhilipp P Lobmaier, Nikolaj Kunøe, Michael Gossop, et al.CNS Neuroscience & Therapeutics|April 20, 2011
Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic miceJoana M Gil-MohapelCNS Neuroscience & Therapeutics|May 20, 2011
Test-retest reliability during fear acquisition and fear extinction in humansMohamed A Zeidan, Kelimer Lebron-Milad, Johanna Thompson-Hollands, et al.CNS Neuroscience & Therapeutics|January 5, 2011
Parkinson's disease dementia and potential therapeutic strategiesJohn N Caviness, LihFen Lue, Charles H Adler, et al.CNS Neuroscience & Therapeutics|January 5, 2011
Revisiting the diagnosis of schizophrenia: where have we been and where are we going?William R Keller, Bernard A Fischer, William T CarpenterCNS Neuroscience & Therapeutics|December 15, 2010
Ginsenosides and their CNS targetsKhaled Radad, Rudolf Moldzio, Wolf-Dieter RauschCNS Neuroscience & Therapeutics|December 17, 2010
Treatment of the psychostimulant-sensitized animal model of schizophreniaTakahide Shuto, Akinori NishiCNS Neuroscience & Therapeutics|March 28, 2012
High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among ChineseYue Huang, Jing Jing, Xing-Quan Zhao, et al.CNS Neuroscience & Therapeutics|January 25, 2012
Genetic polymorphism of NAT2 metabolizing enzymes on phenytoin pharmacokinetics in Indian epileptic patients developing toxicityM Murali, T Manjari, B Madhuri, et al.Pageof 339